Artivion outlines double-digit revenue growth target for 2025 as AMDS and On-X momentum builds
Source: SeekingAlpha
2025-11-06 23:46:47 ET
More on Artivion
- Artivion, Inc. (AORT) Q3 2025 Earnings Call Transcript
- Artivion, Inc. (AORT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
- Share Growth And Strong Clinical Results Continue To Support The Artivion Story
- Artivion Non-GAAP EPS of $0.16 beats by $0.01, revenue of $113.4M beats by $2.81M
- Seeking Alpha’s Quant Rating on Artivion
Read the full article on Seeking Alpha
For further details see:
Artivion outlines double-digit revenue growth target for 2025 as AMDS and On-X momentum builds
Artivion Inc Com
NASDAQ: AORT
AORT Trading
0.66% G/L:
$36.005 Last:
46,222 Volume:
$36 Open:
AORT Latest News
March 03, 2026 04:10:00 pm
Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
AORT Stock Data
$1,911,105,039
43,774,444
0.76%
91
N/A
Medical Equipment & Supplies
Healthcare
US
Kennesaw
